危重症患者持续肾脏替代治疗中镇痛、抗惊厥及精神药物的给药指南
本文综述了接受持续肾脏替代治疗(CRRT)的危重症患者中常用镇痛药、抗惊厥药和精神药物的药代动力学特点与给药建议。通过检索1980至2020年成人CRRT患者的相关文献,发现此类药代动力学/药效学研究稀疏,但鉴于药物广泛使用、治疗窗窄及剂量不当风险,仍需更多研究指导给药。
要点
- CRRT显著影响药物吸收、分布、代谢和清除,需调整给药剂量。
- 镇痛、抗惊厥及精神药物在CRRT患者中的药代动力学研究证据有限。
- 此类药物治疗窗窄,剂量不足或过量风险高,应个体化给药。
核心结论
- 指导CRRT患者镇痛、抗惊厥及精神药物给药的药代动力学/药效学研究稀疏,需更多研究。
研究设计与样本
- 综述,检索1980至2020年成人CRRT患者中评估药物给药的相关文献。
主要发现
- CRRT对药物吸收、分布、转运、代谢和清除等药代动力学因素有显著影响。
- 纳入药代动力学/药效学分析及描述CRRT清除药物的文章,总结实践性原则并给出给药建议。
临床怎么用
- 基于药代动力学/药效学原则,为CRRT危重症患者提供镇痛、抗惊厥及精神药物的给药推荐。
局限性
- 相关药代动力学/药效学研究稀疏,证据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT) is a common complication in critical illness and has a significant impact on pharmacokinetic factors determining drug exposure, including absorption, distribution, transport, metabolism, and clearance. In this review, we provide a practical guide to drug dosing considerations in critically ill patients undergoing CRRT, focusing on the most commonly used analgesic, anticonvulsant, and psychotropic medications in the clinical care of critically ill patients. A literature search was conducted to identify articles in which drug dosing was evaluated in adult patients receiving CRRT between the years 1980 and 2020. We included articles with pharmacokinetic/pharmacodynamic analyses and those that described medication clearance via CRRT. A summary of the data focused on practical pharmacokinetic and pharmacodynamic principles is presented, with recommendations for drug dosing of analgesics, anticonvulsants, and psychotropic medications. Pharmacokinetic and pharmacodynamic studies to guide drug dosing of analgesics, anticonvulsants, and psychotropic medications in critically ill patients receiving CRRT are sparse. Considering the widespread use of these medications, narrow therapeutic index of these drug classes, and risks of over- and underdosing, additional studies in patients receiving CRRT are needed to inform drug dosing.
引用
- Bouajram RH, Awdishu L. A Clinician's Guide to Dosing Analgesics, Anticonvulsants, and Psychotropic Medications in Continuous Renal Replacement Therapy. Kidney Int Rep. 2021. PMID: 34386653. doi:10.1016/j.ekir.2021.05.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。